Sapient Capital LLC bought a new stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 631,609 shares of the company’s stock, valued at approximately $65,340,000. Novo Nordisk A/S makes up about 1.7% of […]
Sapient Capital LLC bought a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm bought 631,609 shares of the company’s stock, valued at approximately $65,340,000. Novo Nordisk A/S accounts for approximately 1.7% of Sapient Capital LLC’s portfolio, making the stock its 10th biggest position. […]
Summit Global Investments reduced its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 22.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,310 shares of the company’s stock after selling 6,927 shares during the quarter. Summit Global Investments’ […]
Summit Global Investments lessened its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 22.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,310 shares of the company’s stock after selling 6,927 shares during the quarter. Summit Global Investments’ holdings […]